首页 | 本学科首页   官方微博 | 高级检索  
     

重症监护病房碳青霉烯类耐药与敏感肺炎克雷伯菌感染患者经济损失及预后研究
引用本文:朱桂红,方英,吕宇,杨玉莲. 重症监护病房碳青霉烯类耐药与敏感肺炎克雷伯菌感染患者经济损失及预后研究[J]. 中国感染控制杂志, 2021, 20(5): 430-436. DOI: 10.12138/j.issn.1671-9638.20217761
作者姓名:朱桂红  方英  吕宇  杨玉莲
作者单位:1. 简阳市人民医院感染管理科, 四川 成都 610070;2. 四川省医学科学院 四川省人民医院医院感染控制中心, 四川 成都 610070;3. 四川省医学科学院 四川省人民医院手术室, 四川 成都 610070
基金项目:四川省卫生健康委员会科研基金(18PJ571)
摘    要:目的 研究耐碳青霉烯类肺炎克雷伯菌(CRKP)感染的重症监护患者预后情况,评价CRKP感染经济负担及死亡风险,为制定有针对性的防控策略提供参考.方法 选取2017年1月—2019年6月某院重症监护病房(ICU)送检标本中检出肺炎克雷伯菌的患者为研究对象.采用回顾性队列研究方法将患者分为CRKP感染组和碳青霉烯类敏感肺炎...

关 键 词:耐碳青霉烯类肺炎克雷伯菌  碳青霉烯类敏感肺炎克雷伯菌  预后  经济损失  重症监护患者
收稿时间:2020-07-10

Economic loss and prognosis of patients with carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae infection in intensive care unit
Gui-hong ZHU,Ying FANG,Yu LYU,Yu-lian YANG. Economic loss and prognosis of patients with carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae infection in intensive care unit[J]. Chinese Journal of Infection Control, 2021, 20(5): 430-436. DOI: 10.12138/j.issn.1671-9638.20217761
Authors:Gui-hong ZHU  Ying FANG  Yu LYU  Yu-lian YANG
Affiliation:1. Department of Infection Management, Jianyang People's Hospital, Chengdu 610070, China;2. Healthcare-associated Infection Control Center, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu 610070, China;3. Operating Room, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu 610070, China
Abstract:Objective To study the prognosis of patients with carbapenem-resistant Klebsiella pneumoniae (CRKP) infection in intensive care unit (ICU), evaluate the economic burden and death risk of CRKP infection, and provide reference for formulating targeted prevention and control strategies. Methods Patients who were isolated Klebsiella pneumoniae from specimens in ICU of a hospital between January 2017 and June 2019 were selected as the research objects,they were divided into CRKP infection group and carbapenem-sensitive Klebsiella pneumoniae (CSKP) infection group by retrospective cohort study, direct hospitalization expense and mortality were analyzed, Kaplan-Meier was adopted to analyze the risk of death, Cox proportional hazards model was used to analyze the influencing factors for risk of death. Results A total of 236 ICU patients were included in analysis, including 175 in CRKP infection group and 61 in CSKP infection group. Lower respiratory tract infection was the major infection in both CRKP infection group and CSKP infection group. Mortality of patients in CRKP infection group was higher than that of CSKP group (28.00% vs 13.11%, P<0.05). The total hospitalization expense of patients in CRKP infection group was 63 648.34 Yuan higher than that of patients in CSKP infection group (Z=-3.923, P<0.001), with an increase of 48.76%; the most significant increase was the expense of antimicrobial agents, which increased by 107.78%. There was significant difference in 30-day death risk between ICU patients in CRKP infection group and CSKP infection group(χ2=5.554, P=0.018), but there was no significant difference in 90-day death risk between two groups of patients (χ2=2.603, P=0.107). Compared with CSKP infection group, risk factors for the increase of 30-day death risk in CRKP infection group were circulatory diseases, mechanical ventilation and age of patients. Conclusion CRKP infection increases hospitalization expense and risk of death in ICU patients. More use of antimicrobial agents is the main cause for the increase of hospitalization expense burden, mechanical ventilation is the main cause for the increase of death risk in ICU patients. Clinical application of antimicrobial agents should be rational, the necessity of mechanical ventilation should be evaluated in time, so as to reduce the emergence of antimicrobial-resistant organisms and improve prognosis of patients.
Keywords:carbapenem-resistant Klebsiella pneumoniae  carbapenem-sensitive Klebsiella pneumoniae  prognosis  economic burden  intensive care unit patient
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号